Search Count: 354
 |
Cryoem Structure Of 40-Residue Arctic (E22G) Beta-Amyloid Fibril Derived By Co-Analysis With Solid-State Nmr | E22G Abeta40
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-09-11 Classification: PROTEIN FIBRIL |
 |
Optimization Efforts For Identification Of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Ihhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.32 Å Release Date: 2024-05-22 Classification: PEPTIDE BINDING PROTEIN Ligands: A1LVB, ACT, SO4 |
 |
Optimization Efforts For Identification Of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction (Ppi) Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2024-05-22 Classification: PEPTIDE BINDING PROTEIN Ligands: A1LVC, ACT, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-05-22 Classification: OXIDOREDUCTASE Ligands: ORO, FMN, GOL, ACT, SO4, A1LYU |
 |
Organism: Escherichia coli k-12
Method: X-RAY DIFFRACTION Resolution:2.81 Å Release Date: 2023-12-13 Classification: TRANSFERASE Ligands: 7TG |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2023-06-28 Classification: IMMUNE SYSTEM Ligands: EDO |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.19 Å Release Date: 2023-06-28 Classification: IMMUNE SYSTEM |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.19 Å Release Date: 2023-06-28 Classification: IMMUNE SYSTEM Ligands: EDO, ACT |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.27 Å Release Date: 2023-06-28 Classification: IMMUNE SYSTEM Ligands: EDO |
 |
Methyl And Fluorine Effects In Novel Orally Bioavailable Keap1/Nrf2 Ppi Inhibitor For Treatment Of Chronic Kidney Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-06-14 Classification: PEPTIDE BINDING PROTEIN Ligands: SGO, DTT, SO4 |
 |
Methyl And Fluorine Effects In Novel Orally Bioavailable Keap1/Nrf2 Ppi Inhibitor For Treatment Of Chronic Kidney Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2023-06-14 Classification: PEPTIDE BINDING PROTEIN Ligands: SIU, SO4 |
 |
Methyl And Fluorine Effects In Novel Orally Bioavailable Keap1/Nrf2 Ppi Inhibitor For Treatment Of Chronic Kidney Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2023-06-14 Classification: PEPTIDE BINDING PROTEIN Ligands: T6I, SO4 |
 |
Wild Type Glta From Bifidobacterium Infantis Jcm 1222 Complexed With Lacto-N-Tetraose
Organism: Bifidobacterium longum subsp. infantis (strain atcc 15697 / dsm 20088 / jcm 1222 / nctc 11817 / s12)
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2022-09-14 Classification: TRANSLOCASE Ligands: SO4 |
 |
Glta N83K Mutant From Bifidobacterium Infantis Jcm 1222 Complexed With Lacto-N-Tetraose
Organism: Bifidobacterium longum subsp. infantis (strain atcc 15697 / dsm 20088 / jcm 1222 / nctc 11817 / s12)
Method: X-RAY DIFFRACTION Resolution:1.56 Å Release Date: 2022-09-14 Classification: TRANSLOCASE Ligands: SO4, ZN |
 |
Organism: Enterobacteria phage t4
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2021-10-27 Classification: HYDROLASE Ligands: TRS, CL, BME |
 |
Organism: Enterobacteria phage t4
Method: X-RAY DIFFRACTION Resolution:1.33 Å Release Date: 2021-10-27 Classification: HYDROLASE Ligands: TRS, BME, CL |
 |
Organism: Enterobacteria phage t4
Method: X-RAY DIFFRACTION Resolution:1.35 Å Release Date: 2021-10-27 Classification: HYDROLASE Ligands: TRS, CL, MBN, BME |
 |
Organism: Enterobacteria phage t4
Method: X-RAY DIFFRACTION Resolution:1.11 Å Release Date: 2021-10-27 Classification: HYDROLASE Ligands: MBN |
 |
Organism: Enterobacteria phage t4
Method: X-RAY DIFFRACTION Resolution:1.27 Å Release Date: 2021-10-27 Classification: HYDROLASE Ligands: TRS, BME, CL, PIH |
 |
Organism: Enterobacteria phage t4
Method: X-RAY DIFFRACTION Resolution:1.31 Å Release Date: 2021-10-27 Classification: HYDROLASE Ligands: TRS, CL, BME, OXE |